Tsukuba, Japan

Shuji Shirotori



 

Average Co-Inventor Count = 6.0

ph-index = 5

Forward Citations = 132(Granted Patents)


Company Filing History:


Years Active: 2010-2014

Loading Chart...
Loading Chart...
Loading Chart...
11 patents (USPTO):Explore Patents

Title: **Shuji Shirotori: Innovator in Antifungal and Antitumor Agents**

Introduction

Shuji Shirotori, a prominent inventor based in Tsukuba, Japan, has made significant contributions to the field of pharmaceutical sciences, particularly through his innovative research resulting in 11 patents. His work primarily focuses on the development of compounds with applications in antifungal and antitumor treatments, showcasing a blend of scientific rigor and practical application.

Latest Patents

Among Shirotori's latest patents is a groundbreaking invention involving heterocycles substituted pyridine derivatives aimed at creating an antifungal agent that boasts excellent efficacy, favorable physical properties, safety, and metabolic stability. The invention details a compound represented by a formula that signifies its unique molecular structure, which enhances its potential effectiveness as a therapeutic agent. Another noteworthy patent describes phenoxypyridine derivative salts and their crystals, showcasing processes for synthesizing these compounds, which demonstrate HGFR inhibitory activity. These compounds are designed for use as anti-tumor agents, angiogenesis inhibitors, and metastasis inhibitors, paving the way for new cancer treatments.

Career Highlights

Shuji Shirotori's career has been marked by his affiliation with Eisai R&D Management Co., Ltd., a leading company in pharmaceutical innovation. His work there has been pivotal in advancing new treatments that address critical health challenges, particularly in oncology and infectious diseases. Over his esteemed career, Shirotori has established himself as a leading figure in pharmaceutical research, contributing significantly to advancements in drug development.

Collaborations

Throughout his career, Shirotori has collaborated with esteemed colleagues, including Keigo Tanaka and Norio Murai. These partnerships have fostered a creative and dynamic research environment, allowing for the exchange of ideas and expertise that are vital for innovation in the pharmaceutical field.

Conclusion

Shuji Shirotori exemplifies the spirit of innovation and dedication in the realm of pharmaceutical research. His notable contributions through various patents and collaborative efforts reflect a commitment to improving health outcomes through scientific advancements. As he continues to push the boundaries of what is possible in drug development, Shirotori remains an inspiring figure in the landscape of innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…